Effects On The Side
🚨 Once hailed as a beacon of hope against COVID-19, Remdesivir's past and present tell a more troubling story. In this episode of Effects on the Side, we delve into: The drug's alarming 53% mortality rate in Ebola trials. Its rapid endorsement during the pandemic despite questionable efficacy. Investigations into financial ties influencing its promotion. The ethical implications of prioritizing profit over patient safety. 🔎 Join us as we uncover the complex web behind Remdesivir and what it means for future medical interventions. 🎙️ Listen now on Effects on the Side.
16 afleveringen
Reacties
0Wees de eerste die een reactie plaatst
Meld je nu aan en word lid van de Effects On The Side community!